SGDase acts by competing with aSMase and ASAH1 to yield their lysoforms, sphingosylphosphorylcholine (SPC) and glucosylsphingosine (GS), respectively, instead of ceramide, which results in the ceramide deficiency in AD skin. This evidence concerns the gene ASAH1 and Alzheimer disease.